FDA Approval Genomics In-Vitro In-Vivo 
XTalks
AUGUST 12, 2020
Related: FDA Approves Rukobia for HIV Patients with Limited Treatment Options. This may help explain why HIV is adequately controlled, but not eradicated, with current treatments. The research study was published in Cell Reports.
Drug Discovery World
JANUARY 17, 2024
CTCs reflect high levels of tumour heterogeneity, represent clonal evolution, and are suitable for treatment selection, real-time longitudinal disease monitoring and in vitro/in vivo culture. Brett Swansiger, Chief Commercial Officer at ANGLE discusses the importance of liquid biopsies in precision medicine trials for cancer.
Expert insights. Personalized for you.
52 
Let's personalize your content